ASP5094

( DrugBank: - / KEGG DRUG: - )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
46	悪性関節リウマチ	2

46. 悪性関節リウマチ

臨床試験数 : 4,356 / 薬物数 : 2,567 - (DrugBank : 415) / 標的遺伝子数 : 192 - 標的パスウェイ数 : 228

trials per page:

Showing 1 to 2 of 2 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03257852 (ClinicalTrials.gov)	September 29, 2017	20/8/2017	A Study to Evaluate the Efficacy and Safety of ASP5094in Patients With Rheumatoid Arthritis on Metho ...	A Phase 2a, Randomized, Placebo-Controlled, Double-Blind, Parallel Group Study to Evaluate the Effic ...	Rheumatoid Arthritis (RA)	Drug: ASP5094;Drug: Placebo;Other: Methotrexate therapy	Astellas Pharma Inc	NULL	Completed	20 Years	N/A	All	66	Phase 2	Japan
2	NCT02698657 (ClinicalTrials.gov)	February 23, 2016	10/2/2016	A Study to Assess the Safety, Tolerability, and Pharmacokinetics of ASP5094Following Multiple Intrav ...	A Phase 1, Randomized, Placebo-controlled, Dose Escalation Study to Assess the Safety, Tolerability, ...	Rheumatoid Arthritis (RA)	Drug: ASP5094;Drug: Placebo	Astellas Pharma Global Development, Inc.	NULL	Completed	18 Years	65 Years	All	30	Phase 1	United States;Poland

First Previous1Next Last